Disclosures: Tae-Hwi Schwantes-An: Target RWE: Consultant, Kung-Hung Lin: Nothing to Disclose, Marco Abreu: Nothing to Disclose, Jingyi Tan: Nothing to Disclose, Xiuqing Guo: Nothing to Disclose, Katherine Yates: Nothing to Disclose, Luca Lotta: Nothing to Disclose, Niek Verweij: Nothing to Disclose, Rohit Loomba: Eli Lilly and Company: Consultant, Jerome Rotter: Nothing to Disclose, Naga Chalasani: Madrigal: Consultant, Zydus, Ipsen, Pfizer, Merck, Altimmune, GSK: Consultant, Exact Sciences: Grant/Research Support, NIH: Grant/Research Support 2566 PATHOGENIC VARIANTS ASSOCIATED WITH MONOGENIC DISORDERS OF DYSLIPIDEMIA IN PATIENTS WITH WELL CHARACTERIZED MASLD Tae-Hwi Schwantes-An 1 Eduardo Vilar-Gomez 1 Marco Abreu 1 Brent Neuschwander-Tetri 2 Miriam Vos 3 Jian Wang 4 Xiuqing Guo 5 Jingyi Tan 5 Robert A Hegele 4 Nicholas Davidson 6 George Hindy 7 Luca Lotta 7 Niek Verweij 7 Jerome Rotter 5 Naga Chalasani 8 , 1 Indiana University School of Medicine, 2 Saint Louis University, 3 Emory University, Children's Healthcare of Atlanta, 4 Robarts Research Institute, 5 Lundquist Institute, 6 Washington University Medical Center, 7 Regeneron, 8 Indiana University Medical Center Background: Dyslipidemia is common in patients with MASLD, and it can sometimes be due to monogenic disorders
However, pricing may vary based on plan selection and is subject to change
By delivering a potent combination of B vitamins and amino acids directly into your system, these treatments can help fight fatigue, increase mental clarity, and leave you feeling energized to tackle whatever comes your way, like our Double Defense Drip
However, caution is advised when combining it with Iron , Caffeine , Alcohol , or certain medications, as these may hinder absorption or deplete your levels
Wang and Chen, 2014), which results in the repression of GL2 (Serna and Martin, 2006
